12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Pasithea Therapeutics KTTA stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1 million.
  • Petros Pharmaceuticals PTPI shares increased by 100.0% to $2.66. The company's market cap stands at $34.9 million.
  • iSpecimen ISPC shares rose 91.89% to $17.04. The market value of their outstanding shares is at $118.6 million.
  • Qualigen Therapeutics QLGN shares increased by 76.0% to $2.2. The company's market cap stands at $64.0 million.
  • Aadi Bioscience AADI stock rose 31.54% to $33.57. The company's market cap stands at $701.4 million.
  • Tonix Pharmaceuticals TNXP shares increased by 22.42% to $0.57. The market value of their outstanding shares is at $250.5 million.
  •  

Losers

  • Adamis Pharmaceuticals ADMP stock declined by 15.98% to $0.74 during Tuesday's pre-market session. The company's market cap stands at $110.1 million. As per the news, the Q3 earnings report came out yesterday.
  • Oramed Pharmaceuticals ORMP stock declined by 8.66% to $17.31. The company's market cap stands at $658.4 million.
  • Amryt Pharma AMYT stock fell 8.45% to $10.3. The company's market cap stands at $655.0 million.
  • Dermata Therapeutics DRMA shares decreased by 8.27% to $2.22. The company's market cap stands at $18.4 million.
  • Reneo Pharmaceuticals RPHM stock decreased by 6.73% to $8.05. The market value of their outstanding shares is at $196.6 million.
  • aTyr Pharma LIFE stock declined by 6.14% to $7.51. The market value of their outstanding shares is at $208.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...